Faes Farma Stock

Faes Farma ROE 2024

Faes Farma ROE

0.14

Ticker

FAE.MC

ISIN

ES0134950F36

WKN

A0MKAC

In 2024, Faes Farma's return on equity (ROE) was 0.14, a -6.88% increase from the 0.15 ROE in the previous year.

Faes Farma Aktienanalyse

What does Faes Farma do?

The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market. Faes Farma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Faes Farma's Return on Equity (ROE)

Faes Farma's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Faes Farma's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Faes Farma's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Faes Farma’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Faes Farma stock

What is the ROE (Return on Equity) of Faes Farma this year?

The ROE of Faes Farma this year is 0.14 undefined.

How has the Return on Equity (ROE) of Faes Farma developed compared to the previous year?

The ROE of Faes Farma has increased by -6.88% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Faes Farma?

A high ROE indicates that Faes Farma generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Faes Farma?

A low ROE can indicate that Faes Farma is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Faes Farma affect the company?

A change in ROE (Return on Equity) of Faes Farma can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Faes Farma?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Faes Farma?

Some factors that can influence Faes Farma's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Faes Farma pay?

Over the past 12 months, Faes Farma paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 4.19 %. For the coming 12 months, Faes Farma is expected to pay a dividend of 0.17 EUR.

What is the dividend yield of Faes Farma?

The current dividend yield of Faes Farma is 4.19 %.

When does Faes Farma pay dividends?

Faes Farma pays a quarterly dividend. This is distributed in the months of February, May, February, August.

How secure is the dividend of Faes Farma?

Faes Farma paid dividends every year for the past 24 years.

What is the dividend of Faes Farma?

For the upcoming 12 months, dividends amounting to 0.17 EUR are expected. This corresponds to a dividend yield of 4.57 %.

In which sector is Faes Farma located?

Faes Farma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Faes Farma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Faes Farma from 7/8/2024 amounting to 0.116 EUR, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Faes Farma pay the last dividend?

The last dividend was paid out on 7/8/2024.

What was the dividend of Faes Farma in the year 2023?

In the year 2023, Faes Farma distributed 0.035 EUR as dividends.

In which currency does Faes Farma pay out the dividend?

The dividends of Faes Farma are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Faes Farma

Our stock analysis for Faes Farma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Faes Farma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.